-
The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology
van der Gaag, S., Oprea-Lager, D. E., Vis, A. N., Hendrikse, H. & Bartelink, I. H., 1 Dec 2026, In: Cancer Chemotherapy and Pharmacology. 96, 1, 74.Research output: Contribution to Journal › Editorial › Academic › peer-review
-
The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of hormone-sensitive prostate cancer – study protocol
van der Gaag, S., Vis, A., Bartelink, I., Hendrikse, H. & Oprea-Lager, D. E., 1 Jun 2026, In: BMJ open. 16, 6, e115888.Research output: Contribution to Journal › Article › Academic › peer-review
-
Leveraging [18F]F-Piflufolastat PET for PBPK Prediction of Tissue Distribution and Therapy Optimization in Prostate Cancer
van der Gaag, S., Veerman, M. J. C., Yilmaz, H., Amsu, J., Pruijn, S. J. V., Oprea-Lager, D. E., Cysouw, M. C. F., Jansen, B. H. E., Yaqub, M. M., Vis, A. N., Hendrikse, H. & Bartelink, I. H., 1 May 2026, In: Clinical and Translational Science. 19, 5, e70583.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
